>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

Office of General Counsel

 

The Office of General Counsel (OGC) is responsible for the legal affairs of ASA.  The OGC represents the Society on a broad range of legal issues, including but not limited to:

  • Administration of the Expert Witness Testimony Review Program
  • Review and negotiation of all Society contracts
  • Intellectual Property matters
  • Antitrust concerns
  • Tax law matters
  • Nonprofit corporate legal issues
  • Governance

This page includes links to important information and resources regarding the Society’s expert witness and intellectual property programs. For further information or questions regarding the OGC, please contact the Washington, D.C. office at (202) 289-2222.

 

ASA Antitrust Statement

ASA Copyright Policy 

License Information for CROSSWALK®, Reverse CROSSWALK, and Relative Value Guide®

Expert Witness Testimony Review Program